These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 9380342)

  • 1. Topical cyclosporin as an adjunct to topical acyclovir treatment in herpetic stromal keratitis.
    Gündüz K; Ozdemir O
    Ophthalmic Res; 1997; 29(6):405-8. PubMed ID: 9380342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of HSV-1 stromal keratitis with topical cyclosporin A: a pilot study.
    Heiligenhaus A; Steuhl KP
    Graefes Arch Clin Exp Ophthalmol; 1999 May; 237(5):435-8. PubMed ID: 10333113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of topical cyclosporin A on herpetic stromal keratitis in a mouse model.
    Yoon KC; Heo H; Kang IS; Lee MC; Kim KK; Park SH; Cho KO
    Cornea; 2008 May; 27(4):454-60. PubMed ID: 18434850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of topical 0.03% flurbiprofen drops in the treatment of herpetic stromal keratitis.
    Vajpayee RB; Dhakal BP; Gupta SK; Sachdev MS; Satpathy G; Honavar SG; Panda A
    Aust N Z J Ophthalmol; 1996 May; 24(2):131-5. PubMed ID: 9199744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical cyclosporine-A versus prednisolone for herpetic stromal keratitis: a randomized controlled trial.
    Peyman A; Nayebzadeh M; Peyman M; Afshari NA; Pourazizi M
    Acta Ophthalmol; 2019 Mar; 97(2):e194-e198. PubMed ID: 30284385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of herpes simplex virus stromal keratitis unresponsive to topical prednisolone 1% with topical cyclosporine 0.05%.
    Rao SN
    Am J Ophthalmol; 2006 Apr; 141(4):771-2. PubMed ID: 16564829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of herpetic keratitis with acyclovir: benefits and problems.
    Ohashi Y
    Ophthalmologica; 1997; 211 Suppl 1():29-32. PubMed ID: 9065935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herpetic Eye Disease Study. A controlled trial of oral acyclovir for herpes simplex stromal keratitis.
    Barron BA; Gee L; Hauck WW; Kurinij N; Dawson CR; Jones DB; Wilhelmus KR; Kaufman HE; Sugar J; Hyndiuk RA
    Ophthalmology; 1994 Dec; 101(12):1871-82. PubMed ID: 7997323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herpetic Eye Disease Study: A Controlled Trial of Topical Corticosteroids for Herpes Simplex Stromal Keratitis.
    Wilhelmus KR; Gee L; Hauck WW; Kurinij N; Dawson CR; Jones DB; Barron BA; Kaufman HE; Sugar J; Hyndiuk RA; Laibson PR; Stulting RD; Asbell PA;
    Ophthalmology; 2020 Apr; 127(4S):S5-S18. PubMed ID: 32200827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bilateral herpetic keratoconjunctivitis.
    Souza PM; Holland EJ; Huang AJ
    Ophthalmology; 2003 Mar; 110(3):493-6. PubMed ID: 12623810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sectorial keratitis and uveitis: differential diagnosis.
    Baltatzis S; Romero-Rangel T; Foster CS
    Graefes Arch Clin Exp Ophthalmol; 2003 Jan; 241(1):2-7. PubMed ID: 12545285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of postoperative immunosuppression after keratoplasty in herpetic keratitis.
    Maier AK; Ozlügedik S; Rottler J; Heussen FM; Klamann MK; Huber KK; Joussen AM; Winterhalter S
    Cornea; 2011 Dec; 30(12):1398-405. PubMed ID: 21996945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herpetic keratitis: persistence of viral particles despite topical and systemic antiviral therapy. Report of two cases and review of the literature.
    Brik D; Dunkel E; Pavan-Langston D
    Arch Ophthalmol; 1993 Apr; 111(4):522-7. PubMed ID: 8385924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral acyclovir for herpes simplex virus eye disease: effect on prevention of epithelial keratitis and stromal keratitis. Herpetic Eye Disease Study Group.
    Arch Ophthalmol; 2000 Aug; 118(8):1030-6. PubMed ID: 10922194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Penetrating keratoplasty in active herpes simplex stromal keratitis].
    Dong X; Shi W; Xie L
    Zhonghua Yan Ke Za Zhi; 2001 Mar; 37(2):118-20. PubMed ID: 11864405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring the inflammatory process in herpetic stromal keratitis: the role of in vivo confocal microscopy.
    Hillenaar T; van Cleynenbreugel H; Verjans GM; Wubbels RJ; Remeijer L
    Ophthalmology; 2012 Jun; 119(6):1102-10. PubMed ID: 22361312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modalities to decrease stromal herpes simplex keratitis reactivation rates.
    Sheppard JD; Wertheimer ML; Scoper SV
    Arch Ophthalmol; 2009 Jul; 127(7):852-6. PubMed ID: 19597103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo antiviral efficacy of a dipeptide acyclovir prodrug, val-val-acyclovir, against HSV-1 epithelial and stromal keratitis in the rabbit eye model.
    Anand BS; Hill JM; Dey S; Maruyama K; Bhattacharjee PS; Myles ME; Nashed YE; Mitra AK
    Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2529-34. PubMed ID: 12766053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for herpes simplex virus epithelial keratitis recurring during treatment of stromal keratitis or iridocyclitis. Herpetic Eye Disease Study Group.
    Wilhelmus KR; Dawson CR; Barron BA; Bacchetti P; Gee L; Jones DB; Kaufman HE; Sugar J; Hyndiuk RA; Laibson PR; Stulting RD; Asbell PA
    Br J Ophthalmol; 1996 Nov; 80(11):969-72. PubMed ID: 8976723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modalities to decrease stromal herpes simplex keratitis reactivation rates.
    Weisberg MP; Sugar J
    Arch Ophthalmol; 2010 Nov; 128(11):1497; author reply 1497-8. PubMed ID: 21060060
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.